Searched for
MERCK
Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leakModerna’s stock price dropped over 25% after trial results for its personalized melanoma vaccine with Merck were disclosed. The decline era...- US targets $500 billion India trade in 3 years, up from record $240 billion, Sergio Gor saysThe United States plans to increase bilateral trade with India to over USD 500 billion in three years. This trade target comes after reachi...
- Sun Pharma to raise Rs 10,000 crore to part-finance Organon dealSun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance b...
- US stocks today: US stocks end higher as healthcare stocks lift Dow, tech a breatherWall Street ended higher on Tuesday, led by the Dow as investors shifted towards healthcare and other value stocks. The S&P 500 also gained...
- Zydus moves closer to US market for Keytruda biosimilar as FDA accepts applicationZydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...
- It’s safety first for gas suppliers at Semicon IncSuppliers want detailed guidelines from the Petroleum and Explosives Safety Organisation (PESO), without which they believe commercial hubs...
- Domestic demand, labour supply give India structural advantage in semiconductor push: Bain & CoIndia's strong domestic demand and demographic dividend give it an advantage in the global semiconductor race, but access to core technolog...
- India's chip gains a democratic shield for global supply chains: PM at Semicon India 2026PM launches chip packaging facilities of Suchi Semicon in Gujarat, and CDIL in Punjab
- PM Modi asks semiconductor CEOs to step up industry participation in next phase of India’s growthPrime Minister Narendra Modi urged India to lead in emerging technologies. He assured industry leaders of a predictable and responsive poli...
- JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...
- Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepinessPharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adul...
- Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilarCipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s can...
- Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...
- US stocks today: US stocks end near flat as hot inflation data clouds Fed rate outlookWall Street ended nearly flat as hotter-than-expected US inflation complicated the Federal Reserve’s interest-rate outlook. Investors turne...
- US lawmakers question Health Secretary Kennedy on vaccine settlement disclosuresUS senators are questioning Health Secretary Robert F. Kennedy Jr.'s explanation regarding his financial stake. His recent statements confl...
- US stocks today: US stocks close higher on tech rebound as Nvidia earnings gain focusUS stocks closed higher as technology and semiconductor shares recovered ahead of Nvidia's earnings. Lower oil prices and Treasury yields o...
- Global Market: China, Hong Kong stocks rebound as healthcare and tech shares rallyChina and Hong Kong stocks rebounded on Thursday, led by healthcare and technology shares, after a sharp selloff in the previous session. F...
- Moderna, Merck breakthrough could usher in wave of cancer vaccinesMerck and Moderna's personalized cancer vaccine shows promise for melanoma patients. This new treatment trains the immune system to target ...
- US stocks: US market rises as yields ease, Moderna lifts healthcare stocksUS stock markets enjoyed a boost as easing bond yields and a spike in Moderna shares contributed to a favorable trading environment. Despit...
- Moderna shares soar 159% in a day after cancer vaccine succeeds in late-stage trialModerna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, redu...
Load More
